Skip to content
10-Q

Quarterly Report

TRIMEDYNE INC

0001019687-15-002016

← back to feed
Filed
May 19, 2015 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · May 15, 2015 18.4M sh
Long Term Debt Q2 2015 · Mar 31, 2015 $26K
Long Term Debt Q2 2015 · Sep 30, 2014 $43K
Short Term Investments Q2 2015 · Mar 31, 2015 $7K
Short Term Investments Q2 2015 · Sep 30, 2014 $8K
Stockholders Equity Q2 2015 · Mar 31, 2015 $3.24M
Stockholders Equity Q2 2015 · Sep 30, 2014 $3.61M
Current Liabilities Q2 2015 · Mar 31, 2015 $760K
Current Liabilities Q2 2015 · Sep 30, 2014 $1.05M
Total Liabilities Q2 2015 · Mar 31, 2015 $788K
Total Liabilities Q2 2015 · Sep 30, 2014 $1.1M
Current Assets Q2 2015 · Mar 31, 2015 $2.84M
Current Assets Q2 2015 · Sep 30, 2014 $3.46M
Total Assets Q2 2015 · Mar 31, 2015 $4.03M
Total Assets Q2 2015 · Sep 30, 2014 $4.71M
Shares Diluted Q2 2015 · Mar 31, 2014 18.4M sh
Shares Diluted Q2 2015 · Mar 31, 2014 18.4M sh
Capex Q2 2015 · Mar 31, 2014 $6K
Cash And Equivalents Q2 2015 · Mar 31, 2014 $1.37M
Cash And Equivalents Q2 2015 · Sep 30, 2013 $1.57M
Eps Diluted Q2 2015 · Mar 31, 2014 $0.00
Eps Diluted Q2 2015 · Mar 31, 2014 −$0.01
Eps Basic Q2 2015 · Mar 31, 2014 $0.00
Eps Basic Q2 2015 · Mar 31, 2014 −$0.01
Sga Expense Q2 2015 · Mar 31, 2014 $472K
Sga Expense Q2 2015 · Mar 31, 2014 $1.02M
Rd Expense Q2 2015 · Mar 31, 2014 $112K
Rd Expense Q2 2015 · Mar 31, 2014 $236K
Net Income Q2 2015 · Mar 31, 2014 −$11K
Net Income Q2 2015 · Mar 31, 2014 −$270K
Operating Income Q2 2015 · Mar 31, 2014 −$33K
Operating Income Q2 2015 · Mar 31, 2014 −$330K
Gross Profit Q2 2015 · Mar 31, 2014 $551K
Gross Profit Q2 2015 · Mar 31, 2014 $927K
Cost Of Revenue Q2 2015 · Mar 31, 2014 $831K
Cost Of Revenue Q2 2015 · Mar 31, 2014 $1.85M
Revenue Q2 2015 · Mar 31, 2014 $361K
Revenue Q2 2015 · Mar 31, 2014 $552K